- Home
- EICC
as 12-18-2024 4:00pm EST
Stocks
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.
| Founded: | N/A | Country: | N/A |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | N/A |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | N/A | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029 News
EICC Breaking Stock News: Dive into EICC Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Eagle Point Income Company Inc. Announces Third Quarter 2024 Financial Results
Business Wire
a month ago
Eagle Point Income Company Inc. Announces First Quarter 2025 Common and Preferred Distributions
Business Wire
2 months ago
Eagle Point Income Company Inc. Schedules Release of Third Quarter 2024 Financial Results on Thursday, November 14, 2024
Thomson Reuters StreetEvents
4 months ago
Q2 2024 Eagle Point Income Company Inc Earnings Call
Business Wire
4 months ago
Eagle Point Income Company Inc. Announces Second Quarter 2024 Financial Results
Business Wire
5 months ago
Eagle Point Income Company Inc. Announces Fourth Quarter 2024 Common and Preferred Distributions
Business Wire
5 months ago
Eagle Point Income Company Inc. Schedules Release of Second Quarter 2024 Financial Results on Tuesday, August 6, 2024
Yahoo Finance Video
6 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
Compare EICC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029 - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.